517
Views
18
CrossRef citations to date
0
Altmetric
Operations Engineering & Analytics

Adaptive risk-based pooling in public health screening

ORCID Icon, &
Pages 753-766 | Received 10 May 2017, Accepted 18 Jan 2018, Published online: 10 Apr 2018

References

  • Amemiya, C.T., Alegria-Hartman, M.J., Aslanidis, C., Chen, C., Nikolic, J., Gingrich, J.C., and De Jong, P.J. (1992) A two-dimensional YAC pooling strategy for library screening via STS and Alu-PCR methods. Nucleic Acids Research, 20(10), 2559–2563.
  • American Red Cross. (2016) Details of tests performed for different infectious agents. Available at: http://www.redcrossblood.org/learn-about-blood/what-happens-donated-blood/blood-testing (accessed July 3, 2016).
  • American Red Cross. (2017) Infectious disease testing. Available at: http://www.redcrossblood.org/learn-about-blood/blood-testing (accessed May 12, 2017).
  • Amos, C.I., Frazier, M.L., and Wang, W. (2000) DNA pooling in mutation detection with reference to sequence analysis. The American Journal of Human Genetics, 66(5), 1689–1692.
  • Aprahamian, H., Bish, D. and Bish, E.K. (2016) Residual risk and waste in donated blood with pooled nucleic acid testing. Statistics in Medicine, 35(28), 5283–5301.
  • Aprahamian, H., Bish, E., and Bish, D.R. (2017a) A complete viral load progression model for HIV, HBV, and HCV. Working paper, Virginia Tech, Blacksburg, VA.
  • Aprahamian, H., Bish, E., and Bish, D.R. (2017b) Optimal risk-based group testing. Working paper, Virginia Tech, Blacksburg, VA.
  • Arnold, S.F. (1977) Generalized group testing procedures. The Annals of Statistics, 5(6), 1170–1182.
  • Barillot, E., Lacroix, B. and Cohen, D. (1991) Theoretical analysis of library screening using an N-dimensional pooling strategy. Nucleic Acids Research, 19(22), 6241–6247.
  • Berger, T., Mandell, J. and Subrahmanya, P. (2000) Maximally efficient two-stage screening. Biometrics, 56(3), 833–840.
  • Bilder, C.R. and Tebbs, J. M. (2012) Pooled-testing procedures for screening high volume clinical specimens in heterogeneous populations. Statistics in Medicine, 31(27), 3261–3268.
  • Bilder, C.R., Tebbs, J. M. and Chen, P. (2010) Informative retesting. Journal of the American Statistical Association, 105(491), 942–955.
  • Black, M.S., Bilder, C. and Tebbs, J.M. (2012) Group testing in heterogeneous populations by using halving algorithms. Journal of the Royal Statistical Society: Series C (Applied Statistics), 61(2), 277–290.
  • Black, M.S., Bilder, C., and Tebbs, J.M. (2015) Optimal retesting configurations for hierarchical group testing. Journal of the Royal Statistical Society: Series C (Applied Statistics), 64(4), 693–710.
  • Bruno, W.J., Knill, E., Balding, D.J., Bruce, D.C., Doggett, N.A., Sawhill, W., Stallings, R.L., Whittaker, C., and Torney, D.C. (1995) Efficient pooling designs for library screening. Genomics, 26(1), 21–30.
  • Bruno, W.J., Sun, F. and Torney, D.C. (1998) Optimizing nonadaptive group tests for objects with heterogeneous priors. SIAM Journal on Applied Mathematics, 58(4), 1043–1059.
  • Burns, K.C. and Mauro, C.A. (1987) Group testing with test error as a function of concentration. Communications in Statistics-Theory and Methods, 16(10), 2821–2837.
  • Centers for Disease Control and Prevention. (2015a). Selected STDs by age, race/ethnicity, and gender, 1996-2014 request. Available at: http://wonder.cdc.gov/std-race-age.html (accessed October 21, 2015).
  • Centers for Disease Control and Prevention. (2015b). Sexually transmitted disease surveillance 2014. available at: http://www.cdc.gov/std/stats14/surv-2014-print.pdf (accessed November 5, 2016).
  • Centers for Disease Control and Prevention. (2015c). Tracking the Hidden Epidemics, Trends in STDs in the United States, 2000. Available at: https://www.cdc.gov/std/trends2000/trends2000.pdf (accessed October 13, 2015).
  • Dorfman, R. (1943) The detection of defective members of large populations. The Annals of Mathematical Statistics, 14(4), 436–440.
  • Du, D.Z. and Hwang, F.K. (2000) Combinatorial Group Testing and Its Applications, volume 12, World Scientific.
  • El-Amine, H., Bish, E.K., and Bish, D. (2017) Optimal pooling strategies for nucleic acid testing of donated blood considering viral load growth curves and donor characteristics. IIE Transactions on Healthcare Systems Engineering, 7(1), 15–29.
  • Food and Drug Administration. (2016) Guidance for industry: Implementation of acceptable full-length donor history questionnaire and accompanying materials for use in screening donors of blood and blood component. Available at: http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM273685.pdf. (accessed September 27, 2016).
  • Gastwirth, J.L. (2000) The efficiency of pooling in the detection of rare mutations. The American Journal of Human Genetics, 67(4),,1036–1039.
  • Graff, L.E. and Roeloffs, R. (1972) Group testing in the presence of test error; an extension of the Dorfman procedure. Technometrics, 14(1), 113–122.
  • Grimes, J.A., Smith, L., and Fagerberg, K. (2013) Sexually Transmitted Disease: An Encyclopedia of Diseases, Prevention, Treatment, and Issues [2 volumes]: An Encyclopedia of Diseases, Prevention, Treatment, and Issues. ABC-CLIO.
  • Habtesllassie, Y.G., Haines, L.M., Mwambi, H., and Odhiambo, J.W. (2015) Array-based schemes for group screening with test errors which incorporate a concentration effect. Journal of Statistical Planning and Inference, 167 41–57.
  • Hudgens, M.G. and Kim, H.Y. (2011) Optimal configuration of a square array group testing algorithm. Communications in Statistics-Theory and Methods, 40(3), 436–448.
  • Hughes-Oliver, J.M. (2006) Pooling experiments for blood screening and drug discovery, in Screening, Springer, New York, NY, pp. 48–68.
  • Hwang, F.K. (1975) A generalized binomial group testing problem. Journal of the American Statistical Association, 70(352), 923–926.
  • Hwang, F.K. (1976) Group testing with a dilution effect. Biometrika, 63(3), 671–680.
  • Johnson, N.L., Kotz, S. and Wu, X.Z. (1991) Inspection Errors for Attributes in Quality Control, volume 44, CRC Press, Boca Raton, FL.
  • Jones, C.M. and Zhigljavsky, A.A. (2001) Comparison of costs for multi-stage group testing methods in the pharmaceutical industry. Communications in Statistics-Theory and Methods, 30(10),2189–2209.
  • Kacena, K.A., Quinn, S.B., Howell, M.R., Madico, G.E., Quinn, T. and Gaydos, C.A. (1998) Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women. Journal of Clinical Microbiology, 36(2), 481–485.
  • Kim, H.Y. and Hudgens, M.G. (2009) Three-dimensional array-based group testing algorithms. Biometrics, 65(3), 903–910.
  • Kim, H.Y., Hudgens, M.G., Dreyfuss, J.M., Westreich, D. and Pilcher, C.D. (2007) Comparison of group testing algorithms for case identification in the presence of test error. Biometrics, 63(4), 1152–1163.
  • Lewis, J.L., Lockary, V. and Kobic, S. (2012) Cost savings and increased efficiency using a stratified specimen pooling strategy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sexually Transmitted Diseases, 39(1), 46–48.
  • Litvak, E., Tu, X., and Pagano, M. (1994) Screening for the presence of a disease by pooling sera samples. Journal of the American Statistical Association, 89(426), 424–434.
  • McMahan, C.S., Tebbs, J. M. and Bilder, C.R. (2012a) Two-dimensional informative array testing. Biometrics, 68(3), 793–804.
  • McMahan, C.S., Tebbs, J.M. and Bilder, C.R. (2012b) Informative Dorfman screening. Biometrics, 68(1), 287–296.
  • North Carolina State Laboratory of Public Health. (2016) Virology/serology: Chlamydia/Gonorrhea.Available at: http://slph.ncpublichealth.com/virology-serology/chlamydia/default.asp, (accessed November 11, 2016).
  • Phatarfod, R.M. and Sudbury, A. (1994) The use of a square array scheme in blood testing. Statistics in Medicine, 13(22), 2337–2343.
  • Quinn, T.C., Brookmeyer, R., Kline, R., Shepherd, M., Paranjape, R., Mehendale, S., Gadkari, D. and Bollinger, R. (2000) Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS, 14(17), 2751–2757.
  • Saraniti, B.A. (2006) Optimal pooled testing. Health Care Management Science, 9(2), 143–149.
  • Sobel, M. and Groll, P.A. (1959) Group testing to eliminate efficiently all defectives in a binomial sample. Bell System Technical Journal, 38(5), 1179–1252.
  • Sterrett, A. (1957) On the detection of defective members of large populations. The Annals of Mathematical Statistics, 28(4), 1033–1036.
  • Stramer, S.L., Krysztof, D.E., Brodsky, J.P., Fickett, T.A., Reynolds, B., Dodd, R.Y. and Kleinman, S.H. (2013) Comparative analysis of triplex nucleic acid test assays in United States blood donors. Transfusion, 53 2525–2537.
  • Tu, X.M., Litvak, E. and Pagano, M. (1994) Screening tests: Can we get more by doing less? Statistics in Medicine, 13(19–20), 1905–1919.
  • Turner, D.W., Stamey, J. and Young, D.M. (2009) Classic group testing with cost for grouping and testing. Computers & Mathematics with Applications, 58(10), 1930–1935.
  • Turner, D.W., Tidmore, F.E., and Young, D.M. (1988) A calculus based approach to the blood testing problem. SIAM Review, 30(1), 119–122.
  • Venette, R.C., Moon, R.D., and Hutchison, W.D. (2002) Strategies and statistics of sampling for rare individuals. Annual Review of Entomology, 47 143–174.
  • Wein, L.M. and Zenios, S.A. (1996) Pooled testing for HIV screening: Capturing the dilution effect. Operations Research, 44(4), 543–569.
  • Weusten, J., van Drimmelen, H. and Lelie, N. (2002) Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion, 42(5), 537–548.
  • Weusten, J., Vermeulen, M., van Drimmelen, H. and Lelie, N. (2011) Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion, 51(1), 203–215.
  • Zou, S., Stramer, S. and Dodd, R.Y. (2012) Donor testing and risk: Current prevalence, incidence, and residual risk of transfusion-transmissible agents in U.S. allogeneic donations. Transfusion Medicine Reviews, 26(2), 119–128.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.